"We're having a spike of flu definitely," Dr. Pilar Delgado told CBS News Miami.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children. But a new ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

Vaccination of pregnant women against respiratory syncytial virus is linked to a substantial reduction in infants' risk for ...

KUALA LUMPUR, Dec 16 — Sanofi and AstraZeneca’s Beyfortus (Nirsevimab) is now approved by the National ...